442 results
8-K
EX-3.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
19 Apr 24
Amendments to Articles of Incorporation or Bylaws
4:06pm
of the meeting. Meetings of stockholders for any other purpose may be held at such time and place, within or without the State of Delaware, as shall … ) of the General Corporation Law of Delaware.
Section 2. Annual Meeting. The annual meeting of the stockholders of the corporation, for the purpose
S-8
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
1 Mar 24
Registration of securities for employees
4:09pm
solely for the purpose of calculating the registration fee. The maximum price per share and maximum aggregate offering price are based upon
S-8
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
1 Mar 24
Registration of securities for employees
4:09pm
This Registration Statement on Form S-8 is being filed for the purpose of registering an additional 225,000 shares of common stock of Ligand Pharmaceuticals … with the Commission on November 21, 1994, and any amendment or report filed for the purpose of updating such description;
our Annual Report on Form 10-K
8-K/A
o8ok8eq
9 Nov 23
Ligand Reports Third Quarter 2023 Financial Results
9:48pm
8-K
EX-10.1
i95j0vgrnt
17 Oct 23
Entry into a Material Definitive Agreement
7:24pm
8-K
EX-10.1
txz1jh1yp gis
4 Nov 22
Unaudited Pro Forma Condensed Consolidated Financial Statements
4:08pm
425
6oaq5i qljpsvx
3 Oct 22
Business combination disclosure
9:20am
8-K
EX-99.1
l1arxwiu2mtb8
3 Oct 22
Ligand Announces Record Date and Details for Distribution for OmniAb Spin-Off
9:18am
S-3ASR
60tmni37r4x
30 Sep 22
Automatic shelf registration
4:17pm
S-3ASR
EX-1.2
9fel2xp
30 Sep 22
Automatic shelf registration
4:17pm
S-3ASR
EX-4.3
l9ebc7
30 Sep 22
Automatic shelf registration
4:17pm
425
d0gu 5s5i9wet8wedtqd
24 Aug 22
Business combination disclosure
5:21pm
S-8
rduind63ah44753g
10 Aug 22
Registration of securities for employees
4:05pm